NCT02279108View on ClinicalTrials.gov

Study Assessing The Interest of Indocyanine Green Fluorescence Imaging With Radioisotope Method For Sentinel Lymph Node Biopsy in Patients With Breast Cancer

PHASE3CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 30, 2014

Primary Completion Date

May 31, 2016

Study Completion Date

July 31, 2016

Conditions

Breast Neoplasms

Interventions

DRUG

indocyanine green

One injection, 2.5 milligrams per patient, intradermal use

DRUG

isotope

One injection, 20 MBq techntium99, intradermal use

Trial Locations (1)

42055

Centre Hospitalier Universitaire de Saint-Etienne, Saint-Etienne

All Listed Sponsors

lead

Centre Hospitalier Universitaire de Saint Etienne

OTHER

NCT02279108 - Study Assessing The Interest of Indocyanine Green Fluorescence Imaging With Radioisotope Method For Sentinel Lymph Node Biopsy in Patients With Breast Cancer | Biotech Hunter | Biotech Hunter